# Biological Therapy in Treating Patients With Glioblastoma Multiforme

> **NCT00003185** · PHASE2 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 40 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **BIOLOGICAL:** autologous tumor cell vaccine
- **BIOLOGICAL:** sargramostim
- **BIOLOGICAL:** tumor-draining lymph node lymphocyte therapy
- **DRUG:** cyclophosphamide
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00003185
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-08
- **Primary completion:** —
- **Final completion:** 1998-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003185, "Biological Therapy in Treating Patients With Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00003185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*